A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients

Affiliations

• ¹ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea.
• ² Department of Life Science, Ewha Womans University, Seoul, Korea.
• ³ Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
• ⁴ Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea hyoo@skku.edu yhko310@skku.edu.
• ⁵ Department of Health Sciences and Technology, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea Samsung Biomedical Research Institute, Research Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea hyoo@skku.edu yhko310@skku.edu.